vs
Side-by-side financial comparison of CuriosityStream Inc. (CURI) and ENANTA PHARMACEUTICALS INC (ENTA). Click either name above to swap in a different company.
CuriosityStream Inc. is the larger business by last-quarter revenue ($19.2M vs $18.6M, roughly 1.0× ENANTA PHARMACEUTICALS INC). CuriosityStream Inc. runs the higher net margin — -19.7% vs -64.1%, a 44.4% gap on every dollar of revenue. On growth, CuriosityStream Inc. posted the faster year-over-year revenue change (35.8% vs 9.8%). CuriosityStream Inc. produced more free cash flow last quarter ($3.9M vs $-11.8M). Over the past eight quarters, CuriosityStream Inc.'s revenue compounded faster (26.5% CAGR vs 4.5%).
Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.
Enanta Pharmaceuticals Inc is a clinical-stage biotechnology company that develops innovative antiviral therapies for infectious diseases including hepatitis B virus, respiratory syncytial virus (RSV), and SARS-CoV-2. It operates primarily in the U.S. and global markets, partnering with pharmaceutical firms to advance its small molecule drug candidate pipeline for patients with unmet medical needs.
CURI vs ENTA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $18.6M |
| Net Profit | $-3.8M | $-11.9M |
| Gross Margin | — | — |
| Operating Margin | -17.6% | -60.5% |
| Net Margin | -19.7% | -64.1% |
| Revenue YoY | 35.8% | 9.8% |
| Net Profit YoY | -34.6% | 46.4% |
| EPS (diluted) | $-0.07 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $18.6M | ||
| Q3 25 | $18.4M | $15.1M | ||
| Q2 25 | $19.0M | $18.3M | ||
| Q1 25 | $15.1M | $14.9M | ||
| Q4 24 | $14.1M | $17.0M | ||
| Q3 24 | $12.6M | $14.6M | ||
| Q2 24 | $12.4M | $18.0M | ||
| Q1 24 | $12.0M | $17.1M |
| Q4 25 | $-3.8M | $-11.9M | ||
| Q3 25 | $-3.7M | $-18.7M | ||
| Q2 25 | $784.0K | $-18.3M | ||
| Q1 25 | $319.0K | $-22.6M | ||
| Q4 24 | $-2.8M | $-22.3M | ||
| Q3 24 | $-3.1M | $-28.8M | ||
| Q2 24 | $-2.0M | $-22.7M | ||
| Q1 24 | $-5.0M | $-31.2M |
| Q4 25 | -17.6% | -60.5% | ||
| Q3 25 | -24.5% | -121.6% | ||
| Q2 25 | 2.5% | -103.2% | ||
| Q1 25 | 0.5% | -164.3% | ||
| Q4 24 | -27.4% | -138.8% | ||
| Q3 24 | -25.8% | -204.4% | ||
| Q2 24 | -20.6% | -134.6% | ||
| Q1 24 | -30.4% | -192.1% |
| Q4 25 | -19.7% | -64.1% | ||
| Q3 25 | -20.4% | -123.6% | ||
| Q2 25 | 4.1% | -99.7% | ||
| Q1 25 | 2.1% | -151.7% | ||
| Q4 24 | -19.9% | -131.4% | ||
| Q3 24 | -24.3% | -197.3% | ||
| Q2 24 | -16.4% | -126.1% | ||
| Q1 24 | -42.0% | -182.7% |
| Q4 25 | $-0.07 | $-0.42 | ||
| Q3 25 | $-0.06 | $-0.88 | ||
| Q2 25 | $0.01 | $-0.85 | ||
| Q1 25 | $0.01 | $-1.06 | ||
| Q4 24 | $-0.05 | $-1.05 | ||
| Q3 24 | $-0.06 | $-1.36 | ||
| Q2 24 | $-0.04 | $-1.07 | ||
| Q1 24 | $-0.09 | $-1.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $27.3M | $37.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $41.5M | $126.6M |
| Total Assets | $75.7M | $329.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.3M | $37.4M | ||
| Q3 25 | $27.8M | $32.3M | ||
| Q2 25 | $28.1M | $44.8M | ||
| Q1 25 | $33.4M | $60.2M | ||
| Q4 24 | $32.1M | $84.3M | ||
| Q3 24 | $33.2M | $37.2M | ||
| Q2 24 | $39.5M | $35.8M | ||
| Q1 24 | $38.8M | $63.5M |
| Q4 25 | $41.5M | $126.6M | ||
| Q3 25 | $47.2M | $64.7M | ||
| Q2 25 | $49.8M | $79.3M | ||
| Q1 25 | $58.1M | $93.5M | ||
| Q4 24 | $57.8M | $111.8M | ||
| Q3 24 | $62.2M | $128.8M | ||
| Q2 24 | $64.8M | $148.9M | ||
| Q1 24 | $67.0M | $166.1M |
| Q4 25 | $75.7M | $329.5M | ||
| Q3 25 | $74.7M | $280.7M | ||
| Q2 25 | $78.7M | $301.0M | ||
| Q1 25 | $85.3M | $323.0M | ||
| Q4 24 | $86.2M | $348.6M | ||
| Q3 24 | $87.6M | $376.7M | ||
| Q2 24 | $90.9M | $398.8M | ||
| Q1 24 | $94.6M | $413.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.0M | $-11.7M |
| Free Cash FlowOCF − Capex | $3.9M | $-11.8M |
| FCF MarginFCF / Revenue | 20.5% | -63.6% |
| Capex IntensityCapex / Revenue | 0.1% | 0.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-18.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.0M | $-11.7M | ||
| Q3 25 | $4.4M | $-6.5M | ||
| Q2 25 | $2.8M | $17.5M | ||
| Q1 25 | $1.9M | $-13.5M | ||
| Q4 24 | $3.0M | $-16.8M | ||
| Q3 24 | $2.3M | $-10.4M | ||
| Q2 24 | $2.2M | $-14.8M | ||
| Q1 24 | $666.0K | $-28.6M |
| Q4 25 | $3.9M | $-11.8M | ||
| Q3 25 | — | $-7.9M | ||
| Q2 25 | — | $17.4M | ||
| Q1 25 | $1.8M | $-16.0M | ||
| Q4 24 | — | $-25.5M | ||
| Q3 24 | — | $-19.4M | ||
| Q2 24 | — | $-21.3M | ||
| Q1 24 | — | $-30.3M |
| Q4 25 | 20.5% | -63.6% | ||
| Q3 25 | — | -52.5% | ||
| Q2 25 | — | 94.7% | ||
| Q1 25 | 12.2% | -107.4% | ||
| Q4 24 | — | -150.6% | ||
| Q3 24 | — | -132.5% | ||
| Q2 24 | — | -118.6% | ||
| Q1 24 | — | -177.5% |
| Q4 25 | 0.1% | 0.8% | ||
| Q3 25 | 0.0% | 9.6% | ||
| Q2 25 | 0.0% | 0.8% | ||
| Q1 25 | 0.5% | 17.0% | ||
| Q4 24 | 0.0% | 51.6% | ||
| Q3 24 | 0.0% | 61.3% | ||
| Q2 24 | 0.0% | 36.4% | ||
| Q1 24 | 0.0% | 9.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.56× | — | ||
| Q1 25 | 6.03× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
